Search Results

Search Results for "transvaginal mesh"

• $650 Million Settlement in Pradaxa Lawsuit
  Boehringer Ingelheim Pharmaceuticals, Inc., manufacturer of Pradaxa, has agreed to pay $650 million to settle Pradaxa lawsuits filed on behalf of approximately 4,000 injured plaintiffs. Managing partner Ramon Lopez serves on the Plaintiffs Steering Committees both for the Illinois Multi District Li...

• J&J to Pay Over $2.2 Billion in False Marketing Settlement
  Johnson & Johnson (J&J) and its subsidiaries have agreed to pay over $2.2 billion in criminal and civil fines arising out of false marketing claims.  The company allegedly promoted off-label uses for various drugs, and provided kickbacks to doctors and pharmacists for prescribing those drug...

• Another legal decision against Ethicon
  A judge recently ordered Johnson & Johnson’s Ethicon division to pay Irish health care products manufacturer Covidien $176.5 million in damages over a patent dispute, Bloomberg reports. At the conclusion of a non-jury trial, U.S. District Judge Janet Bond Arterton in New Haven, Conn., ruled th...

• Bellwether Cases Selected in Southern District of West Virginia
  The attorneys at Lopez McHugh are actively representing women who claim to have been injured by defective transvaginal mesh products. As a result, we have been keeping a close eye on the developments of the Multidistrict Litigation (known as MDL) in the Southern District of West Virginia. In the MD...

• Medications available for urinary incontinence
  According to the Mayo Clinic, the underlying cause and severity of urinary incontinence determine what type of treatment may be most appropriate. Medication is often used in conjunction with behavioral techniques, such as bladder training, scheduled bathroom trips and fluid and diet management. Whil...

• Medical device regulations criticized
  A story in Canadian news magazine MacLean’s deals with the haphazard nature of medical device regulation, characterizing the problem as a “scandal in the making.” According to the article, flawed oversight of medical devices – essentially any medical product that doesn’t work through a che...

• DePuy to stop making metal hip implants
  DePuy Orthopaedics, a unit of Johnson & Johnson, has announced that it is phasing out production of its metal-on-metal hip implants, according to a story in the New York Times. The all-metal implants feature both a ball and a socket coated in a combination of cobalt and chromium. They were origi...

• Physical therapy a treatment for urinary incontinence
  Treatments for urinary incontinence vary, depending on the underlying cause and the severity. But in some cases, the key to eliminating the condition may be as simple and noninvasive as physical therapy, according to the Mayo Clinic. And while there are pros and cons to different types of treatment,...

• Australian lawmakers taking action on medical devices
  Australian lawmakers are considering legislation to help protect consumers from faulty medical devices, including all-metal hip implants. Newspaper The Australian reports that there is currently no requirement in Australia that sponsors of medical devices, which are companies that don’t produce th...

• J&J rebranding called well-executed PR attempt
  A story in Forbes takes a look at the trend of top global brands issuing public apologies for serious missteps. The story picks out Johnson & Johnson as an example of a company falling back on a new branding campaign in an effort to win back customers who have turned away because of recent probl...